Vendor Portfolio Governance
Vendors
60
SLA Red
14
Deliverables Due
300
Home/vendors
Vendors
Vendor portfolio governance with partitioned access and SLA oversight. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.
Vendor SLA Exceptions
| Item | Details |
|---|---|
| VENDOR-001 | Vendor 1 | Imaging | SLA Amber | deliverables 8 |
| VENDOR-002 | Vendor 2 | eCOA | SLA Red | deliverables 8 |
| VENDOR-003 | Vendor 3 | eCOA | SLA Green | deliverables 8 |
| VENDOR-004 | Vendor 4 | Regulatory | SLA Green | deliverables 8 |
| VENDOR-005 | Vendor 5 | IRT | SLA Red | deliverables 8 |
| VENDOR-006 | Vendor 6 | Regulatory | SLA Amber | deliverables 8 |
| VENDOR-007 | Vendor 7 | Lab | SLA Amber | deliverables 8 |
| VENDOR-008 | Vendor 8 | Safety | SLA Amber | deliverables 8 |
| VENDOR-009 | Vendor 9 | IRT | SLA Red | deliverables 8 |
| VENDOR-010 | Vendor 10 | CRO | SLA Red | deliverables 8 |
Add Vendor SLA Exceptions Entry
Access & Governance Controls
RBAC+ABACStudy Firewall Active
Operational Controls
Study firewalling chips highlight boundary, country constraints, and vendor partition rules.
Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.
Every state change writes immutable audit evidence with actor, timestamp, and object reference.
Next Actions
Filter to portfolio/program/study context.
Open linked tasks, risks, and document evidence.
Escalate blocked items through governed workflow.